Eukaryotic Cell, February 2006, p. 217-225, Vol. 5, No. 2
1535-9778/06/$08.00+0 doi:10.1128/EC.5.2.217-225.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Brian Cox, and
Mick F. Tuite*
Protein Science Group, Department of Biosciences, University of Kent, Canterbury, Kent CT2 7NJ, United Kingdom
Received 23 August 2005/ Accepted 26 October 2005
|
|
|---|
|
|
|---|
Hsp104 is classed as a member of the AAA (ATPases associated with a variety of cellular activities) family of proteins because it has both sequence and functional similarities to other members of this relatively diverse group of cellular proteins (15). A property common to all members of the AAA family is the ability to bind and hydrolyze ATP, which in turn drives the unfolding or disassembly of either protein-protein complexes or protein-DNA complexes. In this role, many of the AAA proteins form oligomers, and in most cases, including that of Hsp104, these are symmetrical ring-like hexamers whose formation is essential for the ATPase-dependent "unfoldase" activity. AAA+ proteins can contain either one (class II) or two (class I) nucleotide binding domains (NBD) of approximately 220 residues, with each NBD containing the characteristic Walker A and B motifs. Both Hsp104 and ClpB are class I AAA+ proteins (15).
In addition to its well-established role in protein remodeling, Hsp104 also plays an essential role in the propagation of all three known yeast prions, [PSI+], [URE3], and [RNQ/PIN+] (20). This intriguing additional dimension to the cellular role played by Hsp104 was first uncovered by the discovery that the [PSI+] prion form of the translation termination factor Sup35p could not be maintained in an hsp104 null mutant (7). Furthermore, overexpression of Hsp104 in a [PSI+] strain also resulted in the loss of the prion, even if Hsp104 was only transiently overexpressed (7, 30). Evidence for Hsp104's role in prion propagation has come from the finding that treating [PSI+] cells with the protein denaturant guanidine hydrochloride (GdnHCl) leads to a loss of the [PSI+] prion (42) as a consequence of inhibition of Hsp104 function (12, 14, 22, 23).
Several models have been proposed to explain the role of Hsp104 in yeast prion propagation, with the most plausible being that Hsp104 (presumably in conjunction with Hsp70 and Hsp40) acts on the highly aggregated dead-end form of the prion protein to generate low-molecular-weight oligomeric forms of the protein that can seed new rounds of protein polymerization (24). We now refer to the seeds as propagons (9). A lack of Hsp104 activity would therefore lead to a failure to generate new propagons, while overexpression of Hsp104 most likely results in complete disaggregation of the prion aggregates back to their soluble form without any seeding activity (24). Consistent with this model is the report that inactivation results in an increase in the size of Sup35p-green fluorescent protein aggregates (46). A recent in vitro polymerization study of the Sup35p NM region (39) is consistent with this model, although this study also suggested that Hsp104 may be required for the de novo formation of small Sup35p oligomers necessary for the nucleation of new Sup35p fibrils. It is clear, however, that Hsp104 is not required for newly synthesized Sup35p to enter polymers in cells (29).
In this paper, we report a functional analysis of an Hsp104 orthologue from the pathogenic yeast species Candida albicans. This species is closely related to S. cerevisiae and encodes orthologues of the S. cerevisiae prion proteins Sup35p (CaSup35p) (32, 35) and Ure2p (CaUre2p) (4, 11). The native CaSup35p protein is unable to establish a prion-like state in S. cerevisiae (32, 35). However, when the N-terminal region of ScSup35p is replaced with the equivalent region from CaSup35p, the chimeric protein is able to convert to an aggregated prion state but is not able to transmit this property to wild-type ScSup35p (35). A form of species barrier to prion transmission therefore exists in fungi (35). Nevertheless, as we show here, the CaHsp104 protein is able to propagate the prion form of ScSup35p in S. cerevisiae, indicating that C. albicans has the key cellular component necessary for prion propagation.
|
|
|---|
(14a) was used. Four different strains of S. cerevisiae were used for this study, as follows. The 74D-694 strain has the genotype MAT
ade1-14 trp1-289 his3
-200 ura3-52 leu2-3,112 [PSI+] (7). Weak and strong [PSI+] variants of this strain were provided by Eric Fernandez-Bellot (University of Kent). The BSC783/4a strain has the genotype MATa SUQ5 ade2-1 his3-11,15 leu2-3,112 ura3-1 [PSI+]. The BSC783/4a
hsp104 strain is strain BSC783/4a with an hsp104::HIS3 disruption and consequently is [psi]. The YJW532 strain has the genotype MATa ade1-14 his3-11,15 leu2-3,112 ura3-1 trp1-1 can1-100 hsp104::HIS3 (p316HpHSP104) [PSI+] [PIN+] and was a kind gift from L. Osherovich and J. Weissman, University of California at San Francisco. E. coli was grown in standard Luria broth (LB). For growth of the various yeast strains, standard growth media were used, and cells were routinely cultured at 30°C as previously described (29). To ensure plasmid retention, transformed cells were grown on a glucose-based synthetic medium (YNBD) containing all necessary supplement combinations (ForMedium, Norwich, United Kingdom). When required, 3 mM GdnHCl was added to yeast extract-peptone-dextrose (YEPD) medium, but this was increased to 5 mM in YNBD. The [PSI+]-mediated suppression of the ade1-14 marker was routinely assessed by the color of colonies formed on 1/4YPD medium (YEPD but with 2.5 g/liter yeast extract rather than 10 g/liter) and confirmed on YNBD-adenine defined medium supplemented with 2.5% (vol/vol) YEPD. The growth conditions used to induce the GAL1 promoter were as previously described (29). DNA transformation. Plasmid DNAs were introduced into E. coli by using the standard CaCl2 transformation method (8). Yeast cells were transformed with plasmid DNA using the whole-cell lithium acetate transformation method, essentially as described by Ito et al. (18).
Cloning and sequencing of C. albicans HSP104 gene. Using the S. cerevisiae HSP104 gene sequence (EMBL accession no. M67479 [GenBank] ), the C. albicans genome database was interrogated using the BLASTN (3) search engine. A single contig (4-2922) was identified that contained a gene whose open reading frame (ORF) encoded a protein showing significant sequence identity to the S. cerevisiae Hsp104 protein sequence. Two oligonucleotides (5'-ATAAAGAATGCGGCCGCCTACCGCATACAAGTGAC-3' and 5'-CATTCTTACGCCGGCGCTTAACTCATTGGCGTCC-3') were designed and used in a high-fidelity PCR to amplify a 3.71-kb DNA fragment from the genomic DNA of C. albicans strain 2005E. The Roche Expand High Fidelity PCR system was used with an assay volume of 50 µl containing the following final concentrations or amounts of reagents: deoxynucleoside triphosphates, 200 µM (each); primers, 300 nM (each); template DNA, 0.75 µg; Mg2+ buffer, 3 mM; and Taq/Pwo polymerase, 2.6 U. The primers produced unique HpaII (5') and NheI (3') restriction sites at either end of the amplified sequence. The HpaII/NheI-digested PCR product was ligated to ClaI/XbaI-digested pRS416 to generate plasmid pUKC1845. This cloning strategy was repeated to generate additional, independently derived clones that were designated pUKC1846, pUKC1847, and pUKC1849.
Using various oligonucleotide primers (synthesized by MWG, Eisberg, Germany), both strands of the cloned CaHSP104 gene were sequenced (by MWG) from two independent clones, namely, pUKC1847 and pUKC1849, using the dideoxy chain termination method.
Plasmid construction. A single-copy LEU2-based plasmid carrying the CaHSP104 gene was generated by digesting pUKC1847 with XhoI/NotI and ligating the product to XhoI/NotI-digested pRS315. The resulting plasmid was designated pUKC1857. Plasmid pUKC1828, a single-copy URA3-based plasmid carrying the ScHSP104 gene, was previously described (12). To construct GAL1-regulated CaHSP104, the coding sequence of the gene was amplified in three independent reactions by high-fidelity PCR using the primers 5'-GTCGGGATCCATCATGGAAGATTTTACAG-3' and 5'-GGATCTCGAGGTTTAGTCAAGTCCAGGTG-3', with plasmid pUKC1847 as the template. The resulting fragments were digested with XhoI/BamHI and ligated into similarly digested plasmid pYES2 (Invitrogen), which is a URA3-based multicopy plasmid carrying the GAL1 promoter. The DNA sequences of the amplified products were confirmed for the three plasmids generated, which were designated pUKC1859, pUKC1860, and pUKC1861. Plasmid pUKC1860 was used in the studies reported here. As a control, the S. cerevisiae HSP104 gene was expressed under the control of the GAL1 promoter, using the plasmid pUKC1832 (12).
Antibody preparation. The peptide CDEDDDEARFTSPGLD, corresponding to the C-terminal 15 amino acids of C. albicans Hsp104p, was synthesized on a Shimadzu PSSM-8 multiple peptide synthesizer using a 9-fluorenylmethoxy carbonyl-based strategy. A cysteine residue (underlined) was added to the N terminus of the peptide to enable coupling to activated keyhole limpet hemocyanin (Calbiochem) carrier protein. The covalently conjugated protein was desalted on a Pharmacia PD-10 column (Sephadex G25), and the concentration of the peptide was determined using the Coomassie Plus protein assay (Pierce). An aliquot (400 µg) of the peptide was used for each immunogen dose, and the immunization schedule was as follows: primary immunization was done with 400 µg conjugate in Freund's complete adjuvant and was followed by boosters at 2 weekly intervals with 400 µg conjugate in Freund's incomplete adjuvant. Serum was obtained after the sixth injection, and Western blot analysis indicated that a 1:2,000 dilution of the unpurified serum was sufficient to detect a protein with the predicted molecular weight with minimal background.
Subcellular fractionation analysis. Protein extracts were prepared by glass bead lysis in the presence of a cocktail of protease inhibitors (Roche) and were separated into soluble and high-molecular-weight fractions as previously described (29), using centrifugation (100,000 x g for 15 min at 4°C). Protein samples were fractionated by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to an Immobilon-PSQ transfer membrane (Millipore). Western blot analysis was carried out using the following primary antibodies: rabbit anti-S. cerevisiae Hsp104 (a gift of S. Lindquist), used at a 1:5,000 dilution, and rabbit anti-C. albicans Hsp104 (obtained as described above), used at a 1:2,000 dilution. Antibody-antigen interactions were revealed using standard chemiluminescence techniques (ECL; Amersham-Pharmacia), utilizing a horseradish peroxidase-conjugated swine anti-rabbit antibody (DAKO P0217) at a 1:5,000 dilution.
Thermotolerance assay. To assay cells' ability to survive at 50°C, a culture of the test strain was first grown in the appropriate defined medium to maintain plasmid selection to an optical density at 600 nm (OD600) of 0.4 to 0.6 at 30°C. The culture was then transferred to 37°C for 1 h, after which the cells were pelleted by centrifugation at 1,500 x g for 5 min at room temperature and then resuspended in an equal volume of fresh medium prewarmed to 50°C. The culture was maintained at 50°C in a water bath for the duration of the experiment. Cell aliquots were then removed every 5 min, diluted as required, and plated onto YEPD plates to determine the numbers of CFU.
Luciferase refolding assay.
The relevant strains were transformed with the plasmid pGPDLuxAB(HIS), which expresses a temperature-sensitive Vibrio harveyi luciferase (31). The transformed cells were grown in appropriate selective medium to an OD600 of approximately 0.2, and the cells were then pelleted and transferred to fresh YEPD, after which the culture was incubated until an OD600 of
0.4 was reached. The culture was then transferred to 46°C, and after 10 min of incubation at this temperature, cycloheximide was added to a final concentration of 10 µg/ml. The culture was then incubated for a further 10 min, after which the cell culture was transferred back to 25°C to allow the cells to recover. Cell samples were taken immediately to determine the level of luciferase activity and then collected every 30 to 45 min for up to 4 h. The luciferase activity was determined by using 300 µl cells plus 5 µl decylaldehyde (Sigma), and the resulting luminescence was immediately quantified using a Bio Orbit 1253 luminometer. Three independent samples were taken per time point.
Nucleotide sequence accession numbers. The CaHSP104 gene sequences in pUKC1847 and pUKC1849 were deposited in the EMBL database under accession numbers AF362390 [GenBank] and AF362391 [GenBank] , respectively.
|
|
|---|
The predicted 899-residue sequences of CaHsp104-1 and CaHsp104-2 showed 64% overall identity to the 908-residue S. cerevisiae Hsp104 protein (ScHsp104), although the N- and C-terminal domains showed significantly lower identities (49.3% and 47.6%, respectively) (Fig. 1A). The two nucleotide binding domains, NBD1 and NBD2, and the mobile linker region between these two domains all showed between 70 and 72% identity. Apart from complete conservation of the Walker A (GxxxxGKT) and Walker B (hhhhDE) motifs, other regions implicated in ATP binding and hydrolysis were also conserved in CaHsp104, particularly the sensor-1 and sensor-2 regions and the associated sensor and substrate discrimination motif originally described by Smith et al. (40) (Fig. 1B). These regions are highly conserved in evolution and are found across a wide evolutionary range of members of the Hsp104/ClpB family, including the Arabidopsis Hsp101 protein (Fig. 1B).
![]() View larger version (47K): [in a new window] |
FIG. 1. The putative Candida albicans HSP104 gene encodes an 899-residue protein that contains all of the key sequence features of the S. cerevisiae molecular chaperone Hsp104. (A) Domain organization of S. cerevisiae Hsp104 (ScHsp104) and C. albicans Hsp104 (CaHsp104) proteins and % amino acid identity at the domain level between the two proteins. The domains were identified by sequence comparison with the Escherichia coli ClpB protein sequence and structure (25). The residues that define the approximate positions of these domains are indicated for ScHsp104 (above) and CaHsp104 (below). (B) Alignment of amino acid sequences of putative Hsp104 orthologues from fungi and Arabidopsis thaliana. Three regions implicated in ATP binding or hydrolysis are shown, with invariant residues boxed. The sequences were obtained from GenBank, and the species are as follows: Sc, Saccharomyces cerevisiae; Sb, Saccharomyces bayanus; Spx, Saccharomyces paradoxus; Sm, Saccharomyces mikatae; Sct, Saccharomyces castellii; Sk, Saccharomyces kudriavzevii; Ca, Candida albicans; Spm, Schizosaccharomyces pombe; Nc, Neurospora crassa; and At, Arabidopsis thaliana. (C) The C-terminal 20 residues of members of the Hsp104 family, including CaHsp104, contain large proportions of the acidic residues D and E (in bold) and two highly conserved residues (LD; boxed) at the extreme C terminus.
|
The CaHSP104 gene is induced by heat shock in C. albicans. In Saccharomyces cerevisiae, HSP104 expression is strongly induced by a variety of stresses, including heat shock and entry into stationary phase (33). This transcriptional response requires two specific cis-acting DNA sequence elements, the AGGG stress element (STRE) and a canonical heat shock element (27, 38). Both elements are present within the first 500 bp of DNA upstream of the CaHSP104 coding sequence, with a single STRE element (AGGGG) present at positions 142 to 146 and two heat shock elements (GAATCATCC [positions 382 to 387] and GAAGGTTCC [positions 263 to 271]).
To assess whether CaHsp104 protein levels increased in heat-stressed cells, a polyclonal antibody was raised against the C-terminal 15 residues of CaHsp104, one of the most highly divergent regions between CaHsp104 and ScHsp104 (Fig. 1). This antibody recognized a protein of the expected molecular weight in total C. albicans extracts which was not recognized by an anti-ScHsp104 polyclonal antibody raised against a C-terminal peptide of ScHsp104 (Fig. 2). The level of the CaHsp104 protein increased in cells in exponential-phase growth when they were switched from 30°C to 37°C for 1 hour, with the level of induction being similar to that seen for ScHsp104 in similarly heat-shocked S. cerevisiae cells (Fig. 2). Furthermore, introduction of the CaHSP104-1 gene into S. cerevisiae on the single-copy plasmid pUKC1847 resulted in the synthesis of a protein with the same electrophoretic mobility as the protein detected by the anti-CaHsp104 antibody in C. albicans cells. Although the intensity of the signal obtained would suggest that there was a higher level of CaHsp104 than the endogenous ScHsp104 levels, since different antibodies were used to detect the two proteins it cannot be concluded that this difference reflects real differences in the numbers of the respective Hsp104 molecules.
![]() View larger version (45K): [in a new window] |
FIG. 2. CaHsp104 is encoded by a heat shock-inducible gene in Candida albicans. (A) Locations of key motifs important for stress-inducible gene transcription in the CaHSP104 promoter. The positions of motifs shown are relative to the A of the ATG codon. (B) Analysis of Hsp104 levels in C. albicans and S. cerevisiae before and after a 1-h heat shock at 37°C. Total protein extracts were separated by SDS-PAGE. Left, C. albicans strain 2005E, probed with anti-CaHsp104 antibody; middle, S. cerevisiae strain BSC783/4a, probed with anti-ScHsp104 antibody (top panel) or with anti-CaHsp104 antibody (bottom panel; the same filter shown in the top panel was stripped and reprobed); right, S. cerevisiae strain BSC783/4a transformed with plasmid pUKC1847, probed with anti-C Hsp104 antibody.
|
The CaHSP104-1 gene was ligated into the plasmid pRS416 to generate the plasmid pUKC1847, and this plasmid was then introduced into strain BSC783/4a carrying an hsp104::LEU2 disruption. The ability of the transformed cells to survive severe heat stress was compared, in a number of independent experiments, to those of the nontransformed hsp104::LEU2 parent strain (Fig. 3A) and cells transformed with the plasmid pUKC1828, which carries the wild-type ScHSP104 gene (12). Both the pUKC1847 and pUKC1828 transformants had the ability to survive heat stress. Likewise, a comparative analysis of the abilities of these three strains to reactivate heat-inactivated luciferase [expressed from plasmid pGPD LuxAB(His)] (31) confirmed that CaHsp104 and plasmid-encoded ScHsp104 could restore the ability of the hsp104::LEU2 parent strain to reactivate the heat-denatured luciferase. This analysis therefore confirmed that CaHsp104 was also able to functionally replace endogenous Hsp104 in S. cerevisiae with respect to its role in thermotolerance (Fig. 3B).
![]() View larger version (19K): [in a new window] |
FIG. 3. CaHsp104 complements both the thermotolerance and protein reactivation properties of ScHsp104. (A) Strain BSC783/4a hsp104 (squares) was transformed with either the plasmid pUKC1847 (diamonds) that carries the CaHSP104 gene or pUKC1828 (triangles), a pRS316-derived plasmid carrying the ScHSP104 gene with its native promoter (12). Plating of cells onto YEPD was used to measure cell survival after exposure to 37°C for 60 min and then 50°C for 0 to 20 min. The resulting numbers of CFU were used to estimate % survival. (B) Reactivation of heat-denatured firefly luciferase was determined in BSC783/4a hsp104 cells (squares) and BSC783/4a hsp104 cells transformed with either pUKC1828 (triangles) or pUKC1847 (diamonds), as described in Materials and Methods. Three independent samples were assayed per time point, and the averages are shown.
|
![]() View larger version (40K): [in a new window] |
FIG. 4. CaHsp104 can mediate propagation of the [PSI+] prion in the absence of ScHsp104. (A) Plasmid shuffling strategy used to assess the ability of CaHsp104 (encoded by the plasmid pUKC1857) to mediate propagation of the [PSI+] prion. Stage I, double transformant expressing both ScHsp104 and CaHsp104; stage II, transformants which had lost the URA3-based plasmid expressing ScHsp104 (pRS316HpHSP104) were selected by growth on 5-fluoroorotic acid-containing medium; stage III, loss of the CaHsp104-expressing plasmid (pUKC1857) by growth on a rich medium (YEPD). (B) Phenotypes of transformants at stages II and III. Colony colors after growth on rich growth medium, in the absence of adenine (ade), and on YEPD containing 3 mM GdnHCl (+GdnHCl) were determined. Two control strains (Con) are also shown for each assay. (C) Subcellular distribution of CaHsp104 and ScSup35p in [PSI+] cells expressing different combinations of CaHsp104 and/or ScHsp104, as indicated. Total protein extracts (T) were fractionated by ultracentrifugation, as described in Materials and Methods, into soluble (S) and pellet (P) fractions. After fractionation of the different samples by SDS-PAGE and transfer to a nitrocellulose filter, the filter was simultaneously probed with both anti-CaHsp104 and anti-ScSup35p, with relative protein positions indicated by arrows.
|
Subcellular fractionation analysis of GdnHCl-treated cells revealed that there was a redistribution of Sup35p from the high-molecular-weight pellet fraction to the soluble fraction in cells expressing ScHsp104. However, such a redistribution was not seen in cells expressing CaHsp104 (Fig. 5B), consistent with the failure of GdnHCl to eliminate the [PSI+] prion in these cells. In both strains, Hsp104 was equally distributed between the soluble and pellet fractions in either the presence or absence of GdnHCl (Fig. 5B).
![]() View larger version (27K): [in a new window] |
FIG. 5. CaHsp104 activity is not inhibited in vivo by growth in the presence of GdnHCl. (A) Effects of GdnHCl on the ability of strain BSC783/4a hsp104 to withstand lethal heat stress at 50°C. For these experiments, the strain was transformed with either the plasmid pUKC1828 carrying the ScHSP104 gene (upper graph) or pUKC1847 carrying the CaHSP104 gene (lower graph). Cells were grown in the absence () or presence ( ) of 3 mM GdnHCl. (B) Subcellular distributions of CaHsp104 and ScSup35p in YJW532 hsp104 [PSI+] cells expressing either ScHsp104 (left panels) or CaHsp104 (right panels). Cells were grown overnight in defined (selective) medium in the absence (upper panels) or presence (lower panels) of 5 mM GdnHCl. Total protein extracts (T) were fractionated by ultracentrifugation, as described in Materials and Methods, into soluble (S) and pellet (P) fractions. After fractionation of the different samples by SDS-PAGE and transfer to a nitrocellulose filter, the filter was simultaneously probed with both anti-CaHsp104 and anti-ScSup35p, with relative protein positions indicated by arrows.
|
The ability of GdnHCl to inhibit thermotolerance in cells expressing just CaHsp104 was also examined. As previously reported (12, 23), the presence of 3 mM GdnHCl significantly inhibited survival after heat shock of [PSI+] cells expressing ScHsp104 (Fig. 5A), but for cells expressing only CaHsp104 (Fig. 3), no inhibition by GdnHCl was observed. Both the prion propagation and thermotolerance functions of CaHsp104 are therefore resistant to the inhibitory effects of GdnHCl, suggesting that these two functions work via a similar molecular mechanism.
Overexpression of CaHsp104 eliminates the [PSI+] prion. The [PSI+] prion is readily eliminated from cells by the overexpression of ScHsp104 (7), and this elimination is more rapid in cells with a weak variant of the [PSI+] prion (10). The CaHSP104-1 gene was therefore placed under the transcriptional control of the GAL1 promoter (plasmid pUKC1860) and introduced into both a weak and a strong variant of the [PSI+] strain 74D-694. For both strains, a significant loss of the [PSI+] prion was observed after growing cells for 10 to 12 generations following the transfer to galactose-based medium, with the greatest loss (87%) being observed with the weak [PSI+] variant (Fig. 6). In a parallel experiment in which ScHSP104 was overexpressed from the GAL1 promoter using the plasmid pUKC1832 (12), after eight or nine generations of growth, 97% of the weak variant cells were [psi], while 22.7% of the strong variant cells were [psi]. In the postinduction cells, there was also a significant increase in the amount of Sup35p found in the soluble fraction for both the weak and strong [PSI+] variants. Consequently, high levels of CaHsp104 in nonstressed cells also result in a failure to propagate the [PSI+] prion in S. cerevisiae, as observed for ScHsp104.
![]() View larger version (46K): [in a new window] |
FIG. 6. Overexpression of CaHSP104 leads to loss of the [PSI+] prion from growing cells. Weak (upper) and strong (lower) [PSI+] variants of strain 74D-694 were transformed with the plasmid pUKC1860 that expresses the CaHSP104 gene under the control of the galactose-inducible GAL1 promoter. Cells were initially grown overnight in glucose-based medium (Glu) before being switched to a preinduction medium containing raffinose (Raf) for a further one to three generations. Galactose (Gal) was then added, and the cells were incubated for a further eight to nine generations. Total extracts (T) were prepared from cells at each of the three stages, and the subcellular distributions of CaHsp104 and ScSup35p in the cells were analyzed as described in the legend to Fig. 5, looking at both soluble (S) and pellet (P) fractions. In addition, cells were taken from each stage and plated onto 1/4YPD to determine the % of cells that were prion-free (i.e., [psi]), as indicated.
|
|
|
|---|
All fungi for which annotated genome sequences are available carry Hsp104 orthologues, and these orthologues show high degrees of amino acid identity within the two nucleotide binding domains, NBD1 and NBD2 (Fig. 1A), but diverge to a much greater extent at both the N-terminal and C-terminal regions (data not shown). It is notable, however, that the extreme C-terminal region encompassing the last 20 residues contains a large proportion of charged (Asp/Glu) residues, including the Arabidopsis orthologue, where 10 of the last 20 residues are Asp or Glu. With the exception of Schizosaccharomyces pombe Hsp104, the C-terminal residue in plant and fungal Hsp104 proteins (including CaHsp104) is an Asp residue.
The interactions between AAA+ proteins and their substrate(s) are mediated largely through their N- and/or C-terminal regions, which either recognize the substrate directly or may bind adaptor proteins which in turn mediate substrate binding (47). Three Hsp90-binding cochaperones, Sti1p, Cpr7p, and Cnr1p, interact with Hsp104 in respiring cells via the acidic C terminus (1), but although both Sti1p and Cpr7p play a minor, nonessential role in [PSI+] propagation, this interaction appears to be mediated via their regulation of the substrate binding properties of Ssa1p (Hsp70) rather than Hsp104 (19). The extreme C terminus of CaHsp104 (FTSPGLD) contains a C-terminal Asp (underlined), but since CaHsp104 carries out all the known functions of ScHsp104, it is possible that Hsp104-cochaperone interactions may just require a single C-terminal acidic residue.
Comparison of the CaHsp104 and ScHsp104 sequences shows that the N and C termini show <50% amino acid identity, in contrast to the >70% amino acid identity for the NBD1-linker-NBD2 regions of the molecules (Fig. 1A). Yet since both the Ca- and ScHsp104 molecules are able to propagate the [PSI+] prion, the data suggest that heterologous Hsp104 is able to recognize the substrateScSup35pto facilitate disaggregation of the ScSup35p polymer to generate Sup35p-based propagons. Previous structure-function studies have identified the importance of the conserved sequences, important for ATP binding and/or hydrolysis, in the prion propagation properties of Hsp104, including the sensor-1 and sensor-2 motifs (7, 16, 17). These sequences, including the Walker A and B boxes and the sensor-1 and sensor-2 motifs, are conserved between CaHsp104 and ScHsp104 (Fig. 1A and B). In addition, Schirmer et al. (37) have demonstrated that a region within the linker region of Hsp104 (TATAADLRYFA [residues 499 to 509 of the ScHsp104 sequence]) is crucial to the regulation of Hsp104 function, possibly facilitating interdomain communication (6). This sequence is in the CaHsp104 protein (residues 497 to 507) and is part of a stretch of 22 residues (residues 490 to 511) that shows 100% identity between CaHsp104 and ScHsp104. Whether this region is crucial for yeast prion propagation remains to be established.
The continued propagation of the [PSI+] prion depends on a critical level of ScHsp104, since either depletion or overexpression of ScHsp104 can lead to a loss of the prion from dividing cells (7, 46). In our analysis, a direct comparison of the levels of endogenous ScHsp104 versus CaHsp104 in the transformed strains was not possible because different antibodies were used to detect the two proteins. It is therefore not clear whether the continued propagation of the [PSI+] prion requires the same amount of CaHsp104 as ScHsp104, although overexpression of the CaHSP104 gene clearly perturbed the propagation mechanism (Fig. 6).
While three of the assayable functions of Hsp104 seem to be conserved, namely, maintenance of the [PSI+] prion, reactivation of denatured luciferase, and heat shock protection, between CaHsp104 and ScHsp104, there is one important difference: the function of CaHsp104 in vivo is not inhibited by millimolar concentrations of the protein denaturant GdnHCl (Fig. 4 and 5). Jung et al. (23) reported the isolation of an hsp104 mutant that was resistant to GdnHCl-induced elimination of the [PSI+] prion. This mutation was an Asp184Asn substitution, but the corresponding CaHsp104 residue (Asp182) is the same as that in wild-type GdnHCl-sensitive ScHsp104. GdnHCl inhibits the ATPase activity of Hsp104 in vitro by enhancing the binding of nucleotides to the chaperone in its hexameric form, and this in turn may lead to reduced ATP turnover (14). Such binding presumably occurs via a pocket within the hexameric form of the Hsp104 molecule that encompasses residue 184 in ScHsp104. One possibility is that the presence of an Asp residue at this position is not essential for such binding and inhibition, and given the high degree of amino acid conservation in this region, which is located 27 residues from the Walker A box in NBD1, this would suggest that other regions of the Hsp104 molecule play an important role in GdnHCl-induced inhibition.
To date, prions have only been reported for two fungal species, S. cerevisiae and the filamentous fungus Podospora anserina (44), and it remains to be established whether or not other fungal species have endogenous prions that can be effectively propagated during mitosis. Previous studies have shown that although CaSup35p can form self-seeding fibrils in vitro (35), there is no evidence that full-length CaSup35p can be propagated in this form in S. cerevisiae (32). This is most likely because it is unable to interact with the endogenous Sup35p prion, with the reason for this cross-species barrier being the difference in the extreme N-terminal aggregation domains of these two proteins (35). However, this barrier can be overcome by certain conformational prion variants generated using chimeric Ca/ScSup35pNM lacking the functional C-terminal region of Sup35p (41). No natural variants of either full-length CaSup35p or ScSup35p that can cross transmit have yet been described. The presence of the key chaperone for the propagation of S. cerevisiae prions in C. albicans and its ability to facilitate the propagation of ScSup35p as a prion suggest that the cellular machinery necessary for prion propagation exists in C. albicans. The development of a sensitive assay, such as that based on readthrough of a stop codon in either the ADE1 or ADE2 gene, is now required in order to search for CaSup35p-based prions in C. albicans.
We thank Eric Fernandez-Bellot, Susan Lindquist, and Lev Osherovich for various reagents used in this study and Justin O'Sullivan, Mikayala King, and Martin Carden for help in the early phases of this project.
Present address: L.B.M.S.-UMR-CNRS 5095, Universite Victor Segalen, Bordeaux 2, 146 rue Leo Saignat, 33076 Bordeaux, France. ![]()
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»